Boundless Bio, Inc. (BOLD) vs Spectral AI, Inc. (MDAI)

A side-by-side comparison of Boundless Bio, Inc. and Spectral AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BOLD

Boundless Bio, Inc.

$58M

$2.56HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT

MDAI

Spectral AI, Inc.

$55M

$1.73HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

Total return — BOLD vs MDAI

growth of $100 · dividends reinvested · last 3y

BOLD -81.8% (-43.3%/yr)MDAI -20.7% (-7.4%/yr)MDAI compounded faster over this window

BOLD MDAI

BOLD vs MDAI: by the numbers

•BOLD is the larger company ($58M vs $55M market cap).
•Both run net losses; BOLD's is the smaller (0.00% vs -69.27% net margin).

Metrics side by side

Valuation

Metric	BOLD	MDAI
P/S ratio	N/A	3.64
P/B ratio	0.87	N/A

Profitability

Metric	BOLD	MDAI
Gross margin	0.00%	41.51%
Operating margin	0.00%	-43.78%
Net margin	0.00%	-69.27%
ROE	-58.99%	N/A
ROIC	-43.97%	-353.68%

Growth (annualized)

Metric	BOLD	MDAI
Total return CAGR (5Y)	N/A	-29.57%

Go deeper

Full BOLD analysis Full MDAI analysis Interactive comparison tool

Dig into the metrics

Boundless Bio ROE Spectral AI ROE Boundless Bio operating margin Spectral AI operating margin Boundless Bio revenue growth Spectral AI revenue growth Boundless Bio free cash flow Spectral AI free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.